UK markets closed

Assertio Holdings, Inc. (ASRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9600-0.0900 (-8.57%)
At close: 04:00PM EDT
0.9836 +0.02 (+2.46%)
After hours: 07:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.0500
Open1.0300
Bid0.9564 x 200
Ask0.9702 x 400
Day's range0.9500 - 1.0500
52-week range0.7300 - 7.5800
Volume1,416,916
Avg. volume1,022,233
Market cap91.32M
Beta (5Y monthly)1.00
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Assertio to Present at the Citizens JMP Life Sciences Conference in New York City

    LAKE FOREST, Ill., May 10, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that Ajay Patel, Chief Financial Officer, will present at the Citizens JMP Life Sciences Conference to be held May 13, 2024 in New York City. The Company will host a group presentation at 12:00 pm Eastern Time, and be available for individual meeti

  • GlobeNewswire

    Assertio Reports First Quarter 2024 Financial Results

    First Quarter Net Product Sales of $31.9 Million Rolvedon Growth Continues, with $14.5 million in Net Product Sales $7.5 Million in Cash Flow from Operations Increases Cash to $80.7 Million LAKE FOREST, Ill., May 06, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today reported financial results for the first quarter ended March 31, 202

  • GlobeNewswire

    Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024

    LAKE FOREST, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will release first quarter 2024 financial results on Monday, May 6, 2024, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m.